<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250622066216N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-12-04</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Effect of massage therapy on neonatal hyperbilirubinemia</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of two massage-therapy methods on defecation of newborns with indirect hyperbilirubinemia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-10-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/84388</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Neonatal indirect hyprerbilirubinemia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1: The Spinal massage therapy group is based on standard guidelines and under the supervision of a physical medicine professor. This massage is performed on hospitalized newborns with hyperbilirubinemia. These newborns receive the main treatment of phototherapy in the ward to reduce jaundice, and abdominal massage therapy is performed as an adjuant treatment during the hospitalization period, three times a day, each time for 15 minutes. The mother is taught how to perform the massages, and a trained nurse also monitors the proper implementation of the massages. All these newborns receive the standard treatment for jaundice, which is phototherapy. The massages are also written on a pamphlet and the steps are taught in simple language. Intervention 2: Intervention group 2:The abdominal massage therapy group is based on standard guidelines and under the supervision of a physical medicine professor. This massage is performed on hospitalized newborns with hyperbilirubinemia. These newborns receive the main treatment of phototherapy in the ward to reduce jaundice, and abdominal massage therapy is performed as an adjuant treatment during the hospitalization period, three times a day, each time for 15 minutes. The mother is taught how to perform the massages, and a trained nurse also monitors the proper implementation of the massages. All these newborns receive the standard treatment for jaundice, which is phototherapy. The massages are also written on a pamphlet and the steps are taught in simple language. Intervention 3: Control group: There are babies who are hospitalized in the ward due to hyperbilirubinemia and only receive phototherapy as the main treatment and do not receive any type of massage as an adjunctive treatment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data can potentially be shared after individuals are anonymized.

When:
Access period starts 6 months after the publication of results

To whom:
Researchers working in academic and scientific institutions

Conditions:
The request submitted to the Scientific Committee of the Neonatal Research Center will be reviewed and, if approved, will be made available.

Where to obtain:
Contact the project manager Dr. Parinaz Alizadeh at the email address p.alizadeh@sbmu.ac.ir

How to obtain:
After sending the request via email, the data will be made available within a maximum of one week if approved by the project manager.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Parinaz Alizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.1146, Shariati Street - above Hosseiniyeh Ershad</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1551415468</zip>
        <telephone>+98 21 2222 7021</telephone>
        <email>p.alizadeh@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Parinaz Alizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 1146, Shariati St-above hosseinieh irshad-Mofid Childrens Hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1551415468</zip>
        <telephone>+98 21 2222 7021</telephone>
        <email>p.alizadeh@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Neonates with indirect hyperbilirubinemia admit for phototherapy
Birth weight above 2500gr
Gestational age above 37 weeks</inclusion_criteria>
      <agemin>1 day</agemin>
      <agemax>28 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Need exchange transfusion
Need medication for hyperbilirubinemia treatment
Direct hyperbilirubinemia
Neonates with abdominal or spinal problems</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Unspecified jaundice</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1: The Spinal massage therapy group is based on standard guidelines and under the supervision of a physical medicine professor. This massage is performed on hospitalized newborns with hyperbilirubinemia. These newborns receive the main treatment of phototherapy in the ward to reduce jaundice, and abdominal massage therapy is performed as an adjuant treatment during the hospitalization period, three times a day, each time for 15 minutes. The mother is taught how to perform the massages, and a trained nurse also monitors the proper implementation of the massages. All these newborns receive the standard treatment for jaundice, which is phototherapy. The massages are also written on a pamphlet and the steps are taught in simple language.</i_keyword>
      <i_keyword>Intervention group 2:The abdominal massage therapy group is based on standard guidelines and under the supervision of a physical medicine professor. This massage is performed on hospitalized newborns with hyperbilirubinemia. These newborns receive the main treatment of phototherapy in the ward to reduce jaundice, and abdominal massage therapy is performed as an adjuant treatment during the hospitalization period, three times a day, each time for 15 minutes. The mother is taught how to perform the massages, and a trained nurse also monitors the proper implementation of the massages. All these newborns receive the standard treatment for jaundice, which is phototherapy. The massages are also written on a pamphlet and the steps are taught in simple language.</i_keyword>
      <i_keyword>Control group: There are babies who are hospitalized in the ward due to hyperbilirubinemia and only receive phototherapy as the main treatment and do not receive any type of massage as an adjunctive treatment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The trend of decreasing indirect bilirubin. Timepoint: Immediately after hospitalization: 6, 12, and 24 hours post-admission. Method of measurement: Measurement of serum bilirubin level by venous blood sampling.</prim_outcome>
      <prim_outcome>Frequency of bowel movements. Timepoint: During the entire hospitalization. Method of measurement: Record in file.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Length of hospital stay. Timepoint: First day of hospitalization - Last day of hospitalization. Method of measurement: The number of days the newborn was hospitalized from the time of admission to the ward until discharge, recorded in the file.</sec_outcome>
      <sec_outcome>Hospitalization cost. Timepoint: First day of hospitalization - Last day of hospitalization. Method of measurement: Estimated daily hospitalization cost in the ward based on the calculated expenses of the hospital's financial department.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-08</approval_date>
        <contact_name>Research Ethics Committees Of School Of Medicine-Shahid Beheshti University Of Medical Science</contact_name>
        <contact_address>Third Floor-Medical University-Chamran Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
